baber/WOPTO huggingface dataset:
Patent JP-5067985-B2 (JP)
IPC: H01L29/47
Filed: 1998-01-21
Granted: 2012-11-07
Abstract: A semiconductor diode structure with a Schottky junction, wherein a metal contact and a silicon carbide semiconductor layer of a first conducting type form the junction and wherein the edge of the junction exhibits a junction termination divided into a transition belt (TB) having gradually increasing total charge or effective sheet charge density closest to the metal contact and a Junction Termination Extension (JTE) outside the transition belt, the JTE having a charge profile with a stepwise or uniformly deceasing total charge or effective sheet charge density from an initial value to a zero or almost zero total charge at the outermost edge of the termination following a radial direction from the center part of the JTE towards the outermost edge of the termination. The purpose of the transition belt is to reduce the electric field concentration at the edge of the metal contact of the Schottky diode, while the purpose of the junction termination extension is to control the electric field at the periphery of the diode.
Patent JP-3761577-B2 (JP)
IPC: A63H33/42
Filed: 1996-05-13
Granted: 2006-03-29
Abstract: PCT No. PCT/EP96/02061 Sec. 371 Date Jan. 10, 1997 Sec. 102(e) Date Jan. 10, 1997 PCT Filed May 13, 1996 PCT Pub. No. WO96/36411 PCT Pub. Date Nov. 21, 1996A sheet has a number of slots laterally defining elements with fold lines extending between said slots. One end of the sheet is attached to the bottom surface of a box and the other end is attached to the inner surface of a lid hinged to the box. The elements can be spatially unfolded, forming at least one plane parallel to one of the said surfaces when it is substantially perpendicular to the other surface, and so that the scenery construction is folded on itself when the lid is swung down on the box.
Patent JP-4004548-B2 (JP)
IPC: C12Q1/6813
Filed: 1998-04-02
Granted: 2007-11-07
Abstract: dsDNA or other interacting molecules, e.g. antibody and antigen, are disassociated by applying an electrical voltage to a solution containing said molecules in a buffer favoring said disassociation e.g. CHES, CAPS OR CAPSO.
Patent ES-2320303-B2 (ES)
Title: Utilizacion de principios activos cosmeticos para proteger a fgf-2.
Inventor: RIVAL DELPHINE
IPC: A61K8/97
Filed: 2007-06-04
Granted: 2010-06-09
Abstract: Utilización de principios activos cosméticos
para proteger a FGF-2. 
     La invención se refiere a una sustancia que
protege a FGF-2 y una composición  para prevenir o
luchar contra la degradación de FGF-2. 
     En particular la invención se refiere a un
extracto de Hibiscus abelmoschus  o hibisco, un extracto de Rábano,
un extracto de bayas de Licio, un extracto  de Banha, un extracto de
Lessonia, un extracto de harina de mostaza, un  extracto de Yi yi
ren, un extracto de Cebada, y/o un extracto de Sésamo,  que protege
a FGF-2 de su degradación. 
     La presente invención permite particularmente la
reestructuración de la  matriz extracelular, en particular a nivel
de la dermis, por ejemplo para  luchar contra el envejecimiento.
Patent ES-2416831-B2 (ES)
Title: Tapiz de revestimiento desmontable
Inventor: JIMÉNEZ JIMÉNEZ JOSÉ
IPC: B44C3/12
Filed: 2011-12-29
Granted: 2014-06-30
Abstract: Tapiz de revestimiento de superficies desmontable caracterizado porque comprende una lámina flexible y elementos decorativos que pueden diferir en alturas y formas, fijados a dicha lámina flexible mediante medios mecánicos en forma y distribución tales que permiten el reemplazo de cada elemento decorativo así como, opcionalmente, la rotación o giro de dichos elementos decorativos respecto al punto o eje de fijación de los mismos. La tipología de medios mecánicos de fijación empleables así como la no implicación de adhesivos o cementos, entre otros, permiten que la colocación, desmontaje y transporte del tapiz sean fáciles y cómodos. Asimismo, el tapiz puede presentar un formato integral o un formato modular.
Patent AU-2001271310-B2 (AU)
Title: Phytoestrogenic Isoflavone Compositions, Their Preparation and Use Thereof for Protection Against and Treatment of Radiation Injury
Inventor: LANDAUER MICHAEL R
IPC: A61K41/00
Filed: 2001-06-12
Granted: 2005-10-06
Abstract: The present invention provides compositions and methods for the prophylactic and therapeutic treatment of animals, including humans from radiation injury. In particular, the present invention provides methods and compositions comprising the isoflavone genistein (4′,5,7-trihydroxyflavone) or phytoestrogenic isoflavonoids.
Patent AU-2001291573-B2 (AU)
Title: Grain fractionation methods and products
Inventor: VASANTHAN THAVARATNAM
IPC: A23L7/10
Filed: 2001-09-26
Granted: 2006-06-15
Abstract: This invention relates to methods for secondary processing of plant material and in particular for the recovery of valuable products such as fiber including beta-glucan, starch, and ethanol solubles from plant material containing starch and fiber. In particular, the invention relates to the preparation of high viscosity beta-glucan products through methods involving sonication/sonification and enzymes.
Patent AU-2002239410-B2 (AU)
Title: CYP1B1 nucleic acids and methods of use
Inventor: HEDLEY MARY LYNNE
IPC: A61K47/30
Filed: 2001-10-31
Granted: 2008-05-01
Abstract: The present invention provides nucleic acids containing transcriptional units that encode CYP1B1 I polypeptides or portions thereof, wherein the transcriptional units lack sequences found in the untranslated region (UTR) or naturally occurring forms of the CYP1B1 transcript. Then nucleic acids of the invention lack transitional repressor elements and thus provide for a system of enhanced translation of the CYP1B1 polypeptide or portions thereof. Also disclosed are methods of administering nucleic acids to a mammal and use in the treatment of proliferative disorders or cancers.
Patent AU-2002245251-B2 (AU)
Title: Local oscillator leakage control in direct conversion processes
Inventor: PETERZELL PAUL E
IPC: H03D3/00
Filed: 2002-01-10
Granted: 2007-02-08
Abstract: A system and method for generating a local oscillator (LO) frequency in a zero intermediate frequency (IF) receiver or transmitter is presented. A signal is received from a voltage controlled oscillator (VCO). The signal has a VCO frequency. The VCO frequency is divided by a number N to produce a signal having a divided-down frequency. The signal having the VCO frequency is then mixed with the signal having the divided-down frequency to produce an output signal having an output frequency. Local oscillator leakage is reduced. Thus, the receiver or transmitter may operate in multiple wireless communication bands and modes and meet the associated specifications.
Patent AU-2002301109-B2 (AU)
Title: Method for the prediction of preeclampsia and other diseases
Inventor: ARBOGAST BRADLEY W
IPC: G01N33/66
Filed: 2002-09-20
Granted: 2006-03-30
Abstract: The invention disclosed is a process for determining the cytoprotective activity of plasma that prevents the destruction of endothelial cells and forestalls the development of a number of diseases such as atherosclerosis, preeclampsia, edema, nephrotic syndrome, and stroke. The present invention includes a method of diagnosing a patient's proclivity to develop a disease having a correlation to a reduction in the concentration of pI 5.6 albumin in the plasma by determining a value indicative of the concentration of the pI 5.6 albumin that is not bound to VLDL ("free pI 5.6 albumin") in the patient's blood serum. The preferred embodiment of the process utilizes in vitro methods to obtain an indicator of the free pI 5.6 albumin instead of directly measuring the concentration of the free pI 5.6 albumin. The preferred method comprises the steps of:(a) providing a plasma sample containing free albumin, triglycerides, very low density lipoproteins, low density lipoproteins, and non-esterified fatty acids bound to the free albumin;(b) determining the concentration of the free albumin;(c) determining the concentration of the non-esterified fatty acids bound to the free albumin; and(d) calculating a value indicative of the toxicity preventing ability of the plasma by comparing the concentration of the free albumin to the concentration of the non-esterified fatty acids bound to the free albumin. The present process does not provide direct measurement of the cytoprotective activity of plasma, but rather, an empirical value which has clinical relevance in identifying patients with a high chance of developing diseases inhibited by pI 5.6 albumin.
Patent AU-2002315598-B2 (AU)
Title: Water-soluble stabilized self-assembled polyelectrolytes
Inventor: RANGER MAXIME
IPC: A61K31/277
Filed: 2002-06-07
Granted: 2006-08-24
Abstract: The present invention is directed toward water-soluble supramolecular self-assemblies and a process for their preparation via micellization of polyelectrolytes through the use of hydrophobic monomeric units. In this invention the polyelectrolyte segment ultimately forms the core of the supramolecular assembly whereas the shell consists of uncharged hydrophilic polymers or oligomers. It has been determined that the inclusion of the hydrophobic co-monomers to the polyelectrolyte segment forming the micelle core leads to a structure of enhanced stability.
Patent AU-2002362205-B2 (AU)
Title: Novel chimeric TNF ligands
Inventor: KIPPS THOMAS J
IPC: A61P35/00
Filed: 2002-12-05
Granted: 2009-12-10
Abstract: The present invention is directed to an isolated polynucleotide sequence encoding a chimeric TNFα, comprising a first nucleotide sequence encoding a domain or subdomain of a tumor necrosis factor ligand other than TNFα, wherein the encoded domain or subdomain replaces a cleavage site of native TNFα, and a second nucleotide sequence encoding a domain or subdomain of native TNFα that binds to a TNFα receptor. The encoded chimeric TNFα is significantly less susceptible to cleavage from the cellular surface and, as a result can increase the concentration of a ligand capable of binding to a TNFα receptor on the surface of a cell. The chimeric TNFα is therefore useful in methods for inducing apoptosis of a cell expressing a TNFα receptor, inducing activation of an immune system cell and treating neoplastic cells, by introducing into the cell of interest an isolated polynucleotide sequence encoding a chimeric TNFα that is expressed on the surface of the cell.
Patent AU-2003206822-B2 (AU)
Title: Use of 15-lipoxygenase inhibitors for treating and preventing bone loss
Inventor: PELTZ GARY ALLEN
IPC: C12Q1/02
Filed: 2003-02-03
Granted: 2008-05-29
Abstract: Methods of treating and preventing bone loss and/or enhancing bone formation are disclosed. The methods utilize 15-lipoxygenase inhibitors. These molecules can be delivered alone or in combination with agents which inhibit bone resorption or additional agents that regulate calcium resorption from bone or enhance bone accumulation. The invention additionally provides methods of diagnosing a predisposition to bone loss.
Patent AU-2003274330-B2 (AU)
Title: Asparaginyl hydroxylases and modulators thereof
Inventor: SCHOFIELD CHRISTOPHER JOSEPH
IPC: G16B15/30
Filed: 2003-10-16
Granted: 2009-06-04
Abstract: A method of identifying, screening, characterising or designing a chemical entity, which mimics or binds to FIH, is described. The method comprises comparing a structural model of FIH with a structural model for said chemical entity, wherein said structural model of FIH is derived from structural factors or structural coordinates determined by subjecting to X-ray diffraction measurements a crystal comprising FIH. Such chemical entities may be used in the treatment of a condition associated with increased or decreased HIF levels or activity.
Patent AU-2004266091-B2 (AU)
Title: Automatic kitesurf release system
Inventor: ROGER DONATIEN
IPC: A63H27/00
Filed: 2004-08-04
Granted: 2009-07-23
Abstract: The device has a clamp (A) arranged on inhaul lines (1) beyond a bar (6) that is connected to outhaul lines (7). The clamp is maintained in closed position by a spring (8) that is fixed between arms (13) of jaws (2). Legs (5) of the clamp are supported against the bar when released by a user, to cause angular rotation of the arms for assuring releasing of inhaul lines and releasing of the user.
Patent AU-2004287170-B2 (AU)
Title: Field-installable connector including stub optical fiber having laser shaped endface
Inventor: WACASTER BRIAN T
IPC: B23K26/08
Filed: 2004-10-28
Granted: 2009-12-10
Abstract: A field-installable connector includes a connector housing and a ferrule having front and rear opposed faces and at least one fiber bore defined longitudinally therethrough. A laser processed stub optical fiber is disposed within the one fiber bore of the ferrule and extends a predetermined distance beyond the rear face of the ferrule. An alignment feature is operable for self-centering the stub optical fiber and a field optical fiber to perform a mechanical splice using a camming means. A method of laser processing a stub optical fiber includes rotating the stub optical fiber and sweeping a laser beam directed at a desired angle back and forth across a surface of the optical fiber. An oscillating motion of the laser is driven by an intermittent sinusoidal signal that results in two deposits of energy onto the stub optical fiber followed by a cooling period before subsequent deposits of energy occur.
Patent AU-2004293211-B2 (AU)
Title: Novel agents for the prevention of Leishmaniosis
Inventor: CAVALEYRA MIREILLE
IPC: C07K14/44
Filed: 2004-11-19
Granted: 2011-04-21
Abstract: The invention relates to nucleic acid constructions, characterized in that they comprise nucleic acids which are isolated in the sense position and which are capable of coding for an immunogenic protein of promastigotes or amastigotes of Leishmania, said nucleic acids responding to one of the sequences SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5 et SEQ ID NO:11 and coding for a protein respectively exhibiting a sequence SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10 et SEQ ID NO:12. The invention can be used for over-expression of the genes of Leishmania coding for an excretion/secretion antigen.
Patent AU-2004308691-B2 (AU)
Title: Inerting method and device for extinguishing a fire
Inventor: WAGNER ERNST-WERNER
IPC: A62C99/00
Filed: 2004-12-29
Granted: 2010-12-16
Abstract: The firefighting system uses carbon dioxide, nitrogen or some other suitable inert gas to flood a room which is on fire and reduce the oxygen concentration from the normal 21% by volume to below 13.8%. Reignition of flames is inhibited below 13.8% oxygen content. At sea level personnel can breathe inert gas and oxygen mixtures down to 10% oxygen without harm. The flooding phase takes 120 seconds, after which the oxygen level reaches a lower threshold (Unterer Schwellwert) - above 10% - and the gas is turned off. Air may leak in, raising the oxygen level. When it reaches an upper threshold (Oberer Schwellwert) - below 13.8% - the gas is turned on again until the lower level is reached.
Patent AU-2005200189-B2 (AU)
Title: Ink jet printhead with ink isolated nozzle actuator
Inventor: SILVERBROOK KIA
IPC: B41J2/055
Filed: 2005-01-18
Granted: 2006-02-16
Abstract: An inkjet nozzle assembly includes a nozzle chamber comprising a floor and a roof. The roof has a moving portion which is moveable relative to the floor. A thermal bend actuator is configured for actuating the moving portion. The thermal bend actuator includes an active beam for connection to drive circuitry and a passive beam mechanically cooperating with the active beam. When a current is passed through the active beam, the active beam expands relative to the passive beam resulting in bending of the moving portion towards the floor of the nozzle chamber. The nozzle opening is defined in the moving portion of the roof, such that the nozzle opening is moveable relative to the floor.
Patent AU-2005213459-B2 (AU)
Title: Vertebral facet joint prosthesis and method of fixation
Inventor: JASON BLAIN
IPC: A61F2/00
Filed: 2005-02-04
Granted: 2011-06-23
Abstract: Devices and methods for altering the spacing and motion at the facet joints of the vertebral column are provided. One embodiment of the invention comprises a prosthesis 34 with surfaces or faces 46, 48 configured to articulate with the facets 20, 22 of the facet joint 28. A retaining member 72 for anchoring the prosthesis 34 within the facet joint 28 is optionally included. Methods for surgically and less invasively implanting the prosthesis 34 and securing the prosthesis 34 to the articular processes or surrounding soft tissue are also provided.
Patent AU-2005272841-B2 (AU)
Title: Fruit skewer
Inventor: FARID TARIQ
IPC: A47J43/28
Filed: 2005-08-10
Granted: 2010-05-13
Abstract: A fruit skewer having an elongated central shaft for receiving and securing fruit, food or non-food items thereon for display or cooking. The portion of the shaft upon which the fruit or other item is to be situated has a cross-sectional area designed to prevent the object through which the skewer is inserted from rotating about the longitudinal axis of the skewer. In the preferred embodiment, the cross-sectional area is in a cross ("+") shape, although other shapes are anticipated, including a "Y" shape as well as a star shape having five or more fins (e.g., "*"). In this embodiment, the end of the skewer is tapered or beveled to allow for the easy insertion of the skewer into the fruit or other object, and the fins are chamfered. At least one projection is provided along the length of the skewer, the projection being provided so as to prevent the item through which the skewer is being inserted from sliding too far down the length of the skewer. A second projection may also be provided along the portion of the skewer on which the fruit or other item is not intended to be situated, this portion serving as the handle for the skewer. This second projection serves to prevent the entire skewer from being inserted too far into a display holder. The end of the skewer along the handle portion is also beveled or tapered so as to allow for the easy insertion of the skewer into the display holder. Multiple projections of varying heights may also be provided along the length of the skewer to allow for the insertion and retention of multiple pieces of fruit.
Patent AU-2005304253-B2 (AU)
Title: Impedance matching of a capacitively coupled RF plasma reactor suitable for large area substrates
Inventor: BELINGER ANDY
IPC: H01J37/32
Filed: 2005-11-11
Granted: 2010-12-23
Abstract: An RF plasma reactor is provided for depositing semi-conductive layers on to very large glass areas. The RF plasma reactor includes a vacuum chamber, a reactor chamber, RF power supply, a matching network, first and second metallic plates located inside the vacuum chamber and a plasma-discharge region defined between the first and second metallic plates. The RF plasma reactor further includes a feed line and an impedance-transformation circuit both of which are electrically connected to the first metallic plate. The impedance-transformation circuit further includes a blocking-tuneable capacitor that transforms an impedance of the reactor.
Patent AU-2006212813-B2 (AU)
Title: Compositions and methods related to soluble G-protein coupled receptors (sGPCRs)
Inventor: VALE WYLIE
IPC: C07K14/435
Filed: 2006-02-08
Granted: 2012-02-02
Abstract: The present invention is directed to compositions and methods related to soluble G-protein coupled receptors (sGPCR). In ceratin aspects the invention includes compositions and methods related to a soluble corticotropin releasing factor receptor related protein, sCRFR2, as well as its effects on CRFR signaling and interaction between CRF family ligand and CRFR receptors, including but not limited to CRFR2, CRFRl and functional or signaling capable variants thereof.
Patent AU-2006235039-B2 (AU)
Title: Pet food compositions comprising two components
Inventor: DEAN SUNVOLD GREGORY
IPC: A23K1/18
Filed: 2006-04-04
Granted: 2011-07-14
Abstract: Pet food compositions comprising a first component comprising a source of protein, a source of fat, and a source of carbohydrate, and a second component comprising a biologic selected from the group consisting of a probiotic component; yeast; enzymes; antibodies; immunoglobulins; cytokines; and combinations thereof are useful for providing pet food compositions that are sufficiently stable such that effective amounts of the biologic are present in the pet food compositions at the time of ingestion by a pet.
Patent AU-2006237559-B2 (AU)
Title: Methods and compositions for modified release of nutritional supplements
Inventor: MCANALLEY SHAYNE A
IPC: A23L33/15
Filed: 2006-03-02
Granted: 2011-08-11
Abstract: The present invention relates to the modified release of nutritional supplements by combining one or more isolated and purified long-chain polysaccharides and one or more nutritional supplements selected from anti-oxidants, vitamins, minerals, amino acids, nucleic acids, mixtures and combinations thereof, wherein the supplement is compressed at a pressure greater that 100 psi.
Patent AU-2006262221-B2 (AU)
Title: Enhanced system and method for managing financial market information
Inventor: WEINSTEIN BERNIE A
IPC: G06F3/0481
Filed: 2006-06-20
Granted: 2012-08-23
Abstract: A System and method are provided for managing financial market Information. According to certain embodiments, the System includes a Computer having a memory, processor, and display. The processor is capable of generating a graphical depiction of the financial market information on the display. The graphical depiction includes a multidimensional representation of a broad range of market information for at least two financial instruments. The graphical depiction resides in a Single window on the display. The financial instruments may include multiple different classes of financial instruments, such as treasuries and futures. Different instruments may be selected and information, including basis information, relevant to the selected instruments may be displayed in a second window.
Patent AU-2006272366-B2 (AU)
Title: Therapeutic honey and method of producing same
Inventor: PETER TAYLOR
IPC: A23L21/25
Filed: 2006-07-19
Granted: 2011-09-22
Abstract: A honey comprising the following features: (i) possesses non-peroxide based antimicrobial activity; and (ii) is derived from .
Patent AU-2006274692-B2 (AU)
Title: Internal combustion engine
Inventor: SAVVAKIS SAVVAS
IPC: F01C1/00
Filed: 2006-06-02
Granted: 2012-07-05
Abstract: An engine with expansion piston located on the end of a motion arm connected to the engine shaft. On the shaft, rotating compression pistons are mounted. The distance between the two piston types allows for the production of great torque. The geometry of expansion chamber and compression chamber is concentric toroidal. A pressure chamber stores the air-fuel mixture coming from the compression chamber to the expansion chamber and is therefore interposed between the two. The timing of the two or more sliding ports attached to the compression chambers determines the compression volume, while the valves control the communication of the pressure chamber with the other chambers.
Patent AU-2007211840-B2 (AU)
Title: Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
Inventor: CHAPLIN JASON HUGH
IPC: C07D307/92
Filed: 2007-02-02
Granted: 2012-03-01
Abstract: The present invention relates generally to substituted benzofurans, benzothiophenes, and indoles and their use as tubulin polymerisation inhibitors.